Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05729932 · ClinicalTrials.gov registry record · Phase 1

Cannabis and Opioid Use Disorder

A Phase 1 study of Opioid Use Disorder, sponsored by University of Kentucky.

Recruiting
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT05729932 is a Phase 1 study of Opioid Use Disorder that is actively recruiting participants, run by University of Kentucky. The registered enrollment target is 15 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05729932, a Phase 1 study of Opioid Use Disorder, is actively recruiting participants, sponsored by University of Kentucky.

RECRUITING
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Conditions Studied

Interventions

  • DRUG Inhaled vaporized cannabis
  • DRUG Intransal opioid

Study Locations (1)

Kentucky

  • Center on Drug and Alcohol Research - Lexington

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-09-10
Est. Completion 2027-06-30
Phase Phase 1

Sponsor

University of Kentucky

54 total trials

What the Registry Record Tells You About NCT05729932

The ClinicalTrials.gov registry entry for NCT05729932 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (100% lower). The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Inhaled vaporized cannabis is the first listed.

NCT05729932 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT05729932 about?

NCT05729932 is a clinical study titled "Cannabis and Opioid Use Disorder". This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

What is the current status of trial NCT05729932?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2024-09-10. Estimated completion is 2027-06-30.

What conditions does trial NCT05729932 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT05729932?

The interventions under investigation include: Inhaled vaporized cannabis (DRUG), Intransal opioid (DRUG).

Who is sponsoring clinical trial NCT05729932?

This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05729932 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.